Clinical Trials for Primary Immune Thrombocytopenia

Find clinical trials for primary immune thrombocytopenia. Discover research opportunities and treatment options in your area.

10 Active Trials Found

Showing 10 trials on this page

Page 1 of 1

Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)

NCT ID: NCT06665308

This clinical trial is looking at how cognitive status, fatigue, and inflammation affect adults with chronic Immune Thrombocytopenia (ITP), a condition where the body doesn't produce enough platele...

Recruiting

Type: observational Locations: London, City Of London, United Kingdom, Seattle, Washington, United States +5 more

Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

NCT ID: NCT05070845

This clinical trial is studying a new treatment called PF-06835375 for adults with a condition known as primary immune thrombocytopenia (ITP), which is when the body doesn’t make enough platelets, ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Liverpool, New South Wales, Australia, Perth, Western Australia, Australia +36 more

A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia

NCT ID: NCT06900920

This clinical trial is testing a new medication called TQB3473 tablets to see if it can help adults with a condition called Primary Immune Thrombocytopenia (ITP). ITP is a disease where the body do...

Recruiting

Phase: PHASE3 Type: interventional Locations: Beijing, Beijing, China, Nanjing, Jiangsu, China +55 more

Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)

NCT ID: NCT06107582

This clinical trial is studying a rare childhood disease called primary immune thrombocytopenia (ITP). In ITP, the body mistakenly destroys its own platelets, which are important for blood clotting...

Recruiting

Type: observational Locations: Tianjin, , China

Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.

NCT ID: NCT06531018

This clinical trial is studying the use of a medication called eltrombopag as a first-line treatment for patients who have recently been diagnosed with Primary Immune Thrombocytopenia (ITP), a cond...

Recruiting

Phase: PHASE1 Type: interventional Locations: Dhaka, , Bangladesh

Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP

NCT ID: NCT06686927

This clinical trial is studying a combination treatment for adults with a severe condition called primary immune thrombocytopenia (ITP), which is when your body doesn't have enough platelets to hel...

Recruiting

Phase: PHASE2 Type: interventional Locations: Wuhan, Hubei, China

A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP

NCT ID: NCT06658834

This clinical trial is studying a new treatment option for adults who have recently been diagnosed with a condition called primary immune thrombocytopenia (ITP), which affects how your body produce...

Recruiting

Phase: PHASE2 Type: interventional Locations: Tianjin, Tianjin, China

The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)

NCT ID: NCT06291415

This clinical trial is studying a new treatment called HMPL-523 for adults with a condition known as Immune Thrombocytopenia (ITP). ITP is a blood disorder where the body doesn't have enough platel...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Adelaide, , Australia +26 more

Observational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010

NCT ID: NCT06466824

This clinical trial is looking at patients with a condition called Primary Immune Thrombocytopenia (ITP), who have had their spleen removed (a surgery known as splenectomy) between January 1, 2010,...

Not yet recruiting

Type: observational

An Observational, Multicenter Study to Evaluate the Safety and Effectiveness of Hetrombopag in Patients With ITP or AA

NCT ID: NCT05333861

This clinical trial is studying the safety and effectiveness of a medication called hetrombopag in patients with two specific blood disorders: Immune Thrombocytopenia (ITP) and Aplastic Anemia (AA)...

Not yet recruiting

Type: observational Locations: Wuhan, Hubei, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions